ECM
FBT icon

Exchange Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Exchange Capital Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-104
Closed -$9K – 239
2016
Q2 		$9K Buy
+104
New +$9.55K ﹤0.01% 174

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return

Exchange Capital Management's FBT Position: Q3 2016 in Review

Exchange Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2016, closing a stake of 104 shares — an estimated $9K sold.

Exchange Capital Management first reported a position in FBT in Q2 2016 and held it in 1 quarter. The position peaked at $9K in Q2 2016. 111 funds tracked by Wall St. Rank hold FBT as of Q3 2016.

  • Exchange Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2016 after selling out during the quarter.
  • Exchange Capital Management sold 104 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2016, an estimated $9K.
  • Exchange Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2016 and held it in 1 quarter.
  • Exchange Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9K in Q2 2016.
  • 111 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2016.

Based on Exchange Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.